介入放射学杂志
介入放射學雜誌
개입방사학잡지
JOURNAL OF INTERVENTIONAL RADIOLOGY
2014年
6期
500-502
,共3页
肝海绵状血管瘤%微波%并发症
肝海綿狀血管瘤%微波%併髮癥
간해면상혈관류%미파%병발증
hepatic cavernous hemangioma%microwave ablation%complication
目的:观察和分析微波消融治疗肝海绵状血管瘤的并发症及其防治。方法2009年7月-2011年5月,对30例肝海绵状血管瘤患者共进行了34例次微波消融治疗。术后观察与微波消融治疗相关的并发症及其预后。结果共发生严重并发症2例(6.7%),其中急性溶血致急性肾衰竭1例,腹壁脓肿1例。术后出现发热18例(60%),短暂性血红蛋白尿4例(13.3%),恶心、呕吐5例(16.7%),术区明显疼痛8例(26.7%),右侧胸腔积液4例(13.3%),肝功能损害24例(80%),白细胞升高11例(36.7%)。无治疗相关死亡病例。结论微波消融治疗肝海绵状血管瘤虽然创伤小、安全性高、疗效好,但对于瘤体范围大或部位复杂者,仍存在有较大的风险。其中有一些并发症是可以及早发现并获得积极救治,避免及减少不良影响。
目的:觀察和分析微波消融治療肝海綿狀血管瘤的併髮癥及其防治。方法2009年7月-2011年5月,對30例肝海綿狀血管瘤患者共進行瞭34例次微波消融治療。術後觀察與微波消融治療相關的併髮癥及其預後。結果共髮生嚴重併髮癥2例(6.7%),其中急性溶血緻急性腎衰竭1例,腹壁膿腫1例。術後齣現髮熱18例(60%),短暫性血紅蛋白尿4例(13.3%),噁心、嘔吐5例(16.7%),術區明顯疼痛8例(26.7%),右側胸腔積液4例(13.3%),肝功能損害24例(80%),白細胞升高11例(36.7%)。無治療相關死亡病例。結論微波消融治療肝海綿狀血管瘤雖然創傷小、安全性高、療效好,但對于瘤體範圍大或部位複雜者,仍存在有較大的風險。其中有一些併髮癥是可以及早髮現併穫得積極救治,避免及減少不良影響。
목적:관찰화분석미파소융치료간해면상혈관류적병발증급기방치。방법2009년7월-2011년5월,대30례간해면상혈관류환자공진행료34례차미파소융치료。술후관찰여미파소융치료상관적병발증급기예후。결과공발생엄중병발증2례(6.7%),기중급성용혈치급성신쇠갈1례,복벽농종1례。술후출현발열18례(60%),단잠성혈홍단백뇨4례(13.3%),악심、구토5례(16.7%),술구명현동통8례(26.7%),우측흉강적액4례(13.3%),간공능손해24례(80%),백세포승고11례(36.7%)。무치료상관사망병례。결론미파소융치료간해면상혈관류수연창상소、안전성고、료효호,단대우류체범위대혹부위복잡자,잉존재유교대적풍험。기중유일사병발증시가이급조발현병획득적겁구치,피면급감소불량영향。
Objective To analyze the complications caused by microwave ablation for hepatic cavernous hemangiomas, and to discuss the prevention and treatment of the complications. Methods During the period from July 2009 to May 2011 at authors’ hospital, a total of 34 times of microwave ablation procedure were carried out in 30 patients with hepatic cavernous hemangiomas. The microwave ablation-related complications were recorded and the prognosis was evaluated. Results Serious complications occurred in 2 patients (6.7%), including acute hemolysis leading to acute renal failure (n = 1) and abdominal wall abscess (n = 1). Postoperative fever was seen in 18 cases (60%), transient hemoglobinuria in 4 cases (13.3%), nausea with vomiting in 5 cases (16.7%), marked pain at the surgical area in 8 cases (26.7%), right pleural effusion in 4 cases (13.3%), hepatic dysfunction in 24 cases (80%) and leukocytosis in 11 cases (36.7%). No treatment-related death occurred. Conclusion For the treatment of hepatic cavernous hemangiomas, microwave ablation is minimally invasive with higher safety and satisfactory effect, although this technique carries somewhat higher risks when the hemangioma is larger or the location of the hemangioma is anatomically complicated. Some of these complications can be early detected and proper management should be actively adopted in order to avoid as well as to minimize the adverse results.